Myeloma treatment at Manipal Hospitals is initiated after a detailed evaluation by a haematologist or oncologist experienced in blood cancers. Treatment decisions are based on the patient's age, disease stage, and general health. It also depends on any complications such as bone lesions, anaemia, or kidney failure.
Initial treatment to reduce the number of abnormal plasma cells may include targeted therapy, immunomodulatory drugs, steroids, and/or chemotherapy. For suitable candidates, high-dose chemotherapy with autologous stem cell transplant may be recommended.
Supportive care is crucial in the treatment of myeloma. Patients may receive medication to strengthen bones and reduce the risk of fractures. Treatment may also involve managing anaemia, preventing infections, and monitoring kidney function. Pain management and regular blood tests are also important aspects of patient care.
Patients require ongoing regular follow-up with blood and urine tests to check treatment response and detect disease progression. Myeloma is considered a chronic illness, but modern treatments can help control the disease. Proper monitoring, medications, and supportive care can help patients to stabilise the disease and maintain a better quality of life.
